Chargement en cours...
Rebasing the Medicare Payment for Dialysis: Rationale, Challenges, and Opportunities
After Medicare’s implementation of the bundled payment for dialysis in 2011, there has been a predictable decrease in the use of intravenous drugs included in the bundle. The change in use of erythropoiesis-stimulating agents, which decreased by 37% between 2007, when its allowance in the bundle was...
Enregistré dans:
| Publié dans: | Clin J Am Soc Nephrol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255403/ https://ncbi.nlm.nih.gov/pubmed/25189926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03830414 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|